$IBM

Thomas Robert David sold $5.8M of IBM

Thomas Robert David (Senior Vice President) sold 25,000 shares of INTERNATIONAL BUSINESS MACHINES CORP (IBM) at $230.32 ($5.76M total) on 2026-08-26.

Original reporting
SEC EDGAR · Thomas Robert David
Published Aug 28, 2026, 8:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 8:53 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IBM
Bearish
medium confidence
Mentioned
$IBM
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IBMBearishLow
01

Why it matters

The disclosed sale provides fresh data on insider sentiment, which can be factored into short-term trading models.

02

Market read

The filing is a primary disclosure of a material insider sale, offering a modest trading signal for IBM.

03

What to watch

Potential upcoming corporate actions (e.g., dividend, buyback) that could offset the negative signal.

Relevance 6/10Novelty 7/10Timing: post-market 2026-08-26

Background

Form 4 filings disclose insider transactions and are considered primary sources of new information.

Company-level read

Ticker impact

$IBMBearishMedium confidence
Context

Senior Vice President Thomas Robert David sold 25,000 IBM shares for $5.76M on 2026-08-26, reducing his stake to 47,800 shares.

Expected impact

Possible short-term downward pressure on IBM stock, but limited impact given the size relative to market cap.

Evidence & confidence

A $5.8M sale by a senior officer is material enough to attract attention, yet IBM's large float dilutes the effect.

Market effects

Minimal impact on the broader technology sector; insider sales are common and not sector-defining.

No significant regional effect; IBM trades primarily on US exchanges.

Limited global relevance; only investors tracking IBM may adjust positions.

Counterpoint

The sale could be unrelated to confidence and merely a personal financial decision, so it may not warrant a sell stance.

Key entities

  • Thomas Robert David

    Senior Vice President at IBM, reporting officer in the filing.

  • IBM

    International Business Machines Corporation, ticker IBM.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ACNMed

Q2 Earnings Recap: Gartner (NYSE:IT) Tops IT Services & Consulting Stocks

Accenture (NYSE:ACN) reported Q2 revenue of $18.72B, up 5.6% YoY, in line with expectations but missed guidance. IBM (NYSE:IBM) reported $17.16B, up 1.1% YoY, missing estimates by 1.5%. Kyndryl (NYSE:KD) reported $3.62B, down 3.3% YoY, missing revenue expectations but beating EPS estimates. ACN and IBM stocks are up 13.3% and 13.6% since reporting, while KD is down 8.5%.

$IBMMed

IBM completes acquisition of HRL to advance quantum ecosystem

IBM has completed its acquisition of HRL Laboratories, a research firm specializing in quantum computing and related technologies. HRL's expertise in silicon-spin qubits and quantum sensing is expected to enhance IBM's quantum hardware roadmap, supporting projects like the IBM Quantum Starling, a fault-tolerant quantum computer planned for 2029. Boeing and General Motors, HRL's former owners, will continue to collaborate with IBM and HRL on quantum applications.

$KDLow

Q2 Rundown: Kyndryl (NYSE:KD) Vs Other IT Services & Consulting Stocks

Kyndryl (KD) reported Q2 revenue of $3.62B, down 3.3% YoY, missing estimates by 0.7% but beating EPS. Gartner (IT) reported $1.68B revenue, up 1.8% YoY, beating estimates. Accenture (ACN) reported $18.72B revenue, up 5.6% YoY, in line with estimates but missed guidance. IBM (IBM) reported $17.16B revenue, up 1.1% YoY, missing estimates by 1.5%. DXC (DXC) reported $3.00B revenue, down 5.1% YoY, in line with estimates but missed EPS.

$IBMLow

IBM Gets Closer to Fault-Tolerant Quantum Computing with New Cryogenic System - TipRanks.com

IBM announced a milestone in quantum computing, connecting and cooling two cryogenic modules to scale quantum computers. The company aims for a 1,000-qubit system by 2027 and a fault-tolerant quantum computer by 2029. IBM shares are slightly down in pre-market trading after a 1.67% gain on Tuesday, closing at $232.67. Analysts give IBM a Moderate Buy consensus with an average price target of $255.78, suggesting 10% upside.